AR119414A1 - Cápsula blanda de gelatina entérica de inhibidor de la bomba de protones - Google Patents

Cápsula blanda de gelatina entérica de inhibidor de la bomba de protones

Info

Publication number
AR119414A1
AR119414A1 ARP200101990A ARP200101990A AR119414A1 AR 119414 A1 AR119414 A1 AR 119414A1 AR P200101990 A ARP200101990 A AR P200101990A AR P200101990 A ARP200101990 A AR P200101990A AR 119414 A1 AR119414 A1 AR 119414A1
Authority
AR
Argentina
Prior art keywords
proton pump
pump inhibitor
soft capsule
gelatin soft
enteric gelatin
Prior art date
Application number
ARP200101990A
Other languages
English (en)
Inventor
Humera Ahmad
Jing Lin
Patrick Mnamara
Original Assignee
Scherer Technologies Llc R P
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scherer Technologies Llc R P filed Critical Scherer Technologies Llc R P
Publication of AR119414A1 publication Critical patent/AR119414A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/07—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)

Abstract

En el presente documento se divulga una composición de cápsula blanda de gelatina entérica que comprende (a) un material de rellano que comprende un inhibidor de la bomba de protones y (b) una composición de cubierta entérica. La composición de gelatina blanda entérica es estable y presenta un perfil de disolución objetivo y características de ruptura de la cápsula de gelatina blanda.
ARP200101990A 2019-07-15 2020-07-15 Cápsula blanda de gelatina entérica de inhibidor de la bomba de protones AR119414A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201962874157P 2019-07-15 2019-07-15

Publications (1)

Publication Number Publication Date
AR119414A1 true AR119414A1 (es) 2021-12-15

Family

ID=74210871

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP200101990A AR119414A1 (es) 2019-07-15 2020-07-15 Cápsula blanda de gelatina entérica de inhibidor de la bomba de protones

Country Status (5)

Country Link
US (1) US20220249455A1 (es)
EP (1) EP3999013A4 (es)
AR (1) AR119414A1 (es)
TW (1) TW202116313A (es)
WO (1) WO2021011177A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20230310328A1 (en) * 2022-04-05 2023-10-05 Captek Softgel International, Inc. Softgel capsules having a fill composition comprising magnesium oxide

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003510348A (ja) * 1999-10-01 2003-03-18 ナトコ ファーマ リミテッド 改良された薬学的組成物およびその製造方法
ES2609059T3 (es) * 2002-10-01 2017-04-18 Banner Life Sciences, LLC Composición entérica para la fabricación de una pared de cápsula blanda
EP1684732A2 (en) * 2003-11-12 2006-08-02 Ranbaxy Laboratories Limited Ibuprofen-containing soft gelatin capsules
CN1729974A (zh) * 2005-08-15 2006-02-08 北京蓝贝望医药科技开发有限公司 雷贝拉唑钠软胶囊及其制备方法
JP2007161694A (ja) * 2005-12-09 2007-06-28 Toyo Seiyaku Kasei Kk ベンズイミダゾール系化合物を含有する安定化された経口用組成物
LT3461503T (lt) * 2007-04-11 2022-03-10 Biomarin Pharmaceutical Inc. Tetrahidrobiopterino, susijusių kompozicijų įvedimo būdai ir matavimo būdai
JP4971298B2 (ja) * 2008-01-11 2012-07-11 ユニメディカル株式会社 腸溶性・徐放性ソフトカプセル及びその製造方法
US9775814B2 (en) * 2014-06-20 2017-10-03 Patheon Softgels Inc. Enteric soft capsule compositions
WO2017095736A1 (en) * 2015-12-01 2017-06-08 R.P. Scherer Technologies, Llc Aspirin soft gelatin capsule as a single active or in combination with other actives
SG11202008208VA (en) * 2018-03-15 2020-09-29 R P Scherer Technologies Llc Enteric softgel capsules

Also Published As

Publication number Publication date
TW202116313A (zh) 2021-05-01
WO2021011177A1 (en) 2021-01-21
EP3999013A4 (en) 2023-07-26
US20220249455A1 (en) 2022-08-11
EP3999013A1 (en) 2022-05-25

Similar Documents

Publication Publication Date Title
CO2021010638A2 (es) Dispositivos de sellado de válvulas cardíacas y dispositivos de suministro para los mismos
ECSP20082717A (es) Composiciones agonistas de gip/glp1
AR119414A1 (es) Cápsula blanda de gelatina entérica de inhibidor de la bomba de protones
FR3103115B1 (fr) Perle fusible de jeu
BR112018075022A2 (pt) aplicador de precisão
CO2019005070A2 (es) Formulaciones farmacéuticas
CO2021014822A2 (es) Obleas de ostomía de cámara perforada, dispositivos que incluyen las mismas, y métodos de aplicación
CO2021018071A2 (es) Cápsulas de gelatina blanda de liberación retardada
UY37560A (es) Combinación de un inhibidor de mcl-1 y un compuesto taxano, usos y composiciones farmacéuticas de ésta
CO2020013571A2 (es) Formulaciones estables de anticuerpos terapéuticos
BR112018071618A2 (pt) métodos, composições e usos relacionados aos mesmos
UY37342A (es) Combinación de un inhibidor de bcl-2 y un inhibidor de mcl1, usos y composiciones farmacéuticas de éstos
CL2016003387A1 (es) Recubrimiento y/o película comestible para la conservación de productos cárneos
DOP2021000174A (es) Dispositivo y métodos de eclosión de huevos y separación de larvas
MX2020006220A (es) Composición de recubrimiento.
BR112021021752A2 (pt) Programação visual para aprendizado profundo
AR122512A1 (es) Cápsulas blandas de liberación retardada
CO2019000596A2 (es) Combinación de un inhibidor de bcl-2 y un inhibidor de mcl1, usos y composiciones farmacéuticas de éstos
BR112015022946A2 (pt) forma de dosagem de cápsula de gelatina macia farmacêutica com goma guar modificada
BR112019006043A2 (pt) métodos, composições e usos relacionados aos mesmos
AR087032A1 (es) Composiciones de capsulas de gelatina y metodos para fabricarlas
CO2019007261A2 (es) Combinación de un inhibidor de mcl-1 y un compuesto taxano, usos y composiciones farmacéuticas de ésta
BR112022012060A2 (pt) Método de configuração de posição, dispositivo terminal e dispositivo de rede
AR101728A1 (es) Formulación de liberación plurimodal de doxilamina y piridoxina y/o metabolitos o sales de las mismas
AR112217A1 (es) Una combinación de un inhibidor de mps1 y un compuesto taxano, usos y composiciones farmacéuticas de ésta